Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
15.52
-0.08 (-0.51%)
Jan 17, 2025, 4:00 PM EST - Market closed
Medifast Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Medifast stock has a target of 17, which predicts an increase of 9.54% from the current stock price of 15.52.
Analyst Consensus: Hold
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Medifast is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Sell → Hold Upgrades $17 → $17 | Sell → Hold | Upgrades | $17 → $17 | +9.54% | Nov 5, 2024 |
| DA Davidson | DA Davidson | Sell Maintains $18 | Sell | Maintains | $18 | +12.76% | Jul 22, 2024 |
| DA Davidson | DA Davidson | Hold → Sell Downgrades $25 → $18 | Hold → Sell | Downgrades | $25 → $18 | +12.76% | Jun 5, 2024 |
| DA Davidson | DA Davidson | Hold Maintains $40 → $25 | Hold | Maintains | $40 → $25 | +61.08% | Apr 30, 2024 |
| DA Davidson | DA Davidson | Hold Maintains $67 → $40 | Hold | Maintains | $67 → $40 | +157.73% | Feb 21, 2024 |
Financial Forecast
Revenue This Year
603.68M
from 1.07B
Decreased by -43.69%
Revenue Next Year
514.95M
from 603.68M
Decreased by -14.70%
EPS This Year
1.79
from 9.10
Decreased by -80.35%
EPS Next Year
0.30
from 1.79
Decreased by -83.05%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 633.3M | 568.2M | 534.7M |
| Avg | 603.7M | 515.0M | 514.3M |
| Low | 580.5M | 469.0M | 499.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -40.9% | -5.9% | 3.8% |
| Avg | -43.7% | -14.7% | -0.1% |
| Low | -45.9% | -22.3% | -3.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.92 | 0.43 | 0.53 |
| Avg | 1.79 | 0.30 | 0.51 |
| Low | 1.68 | 0.19 | 0.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -78.9% | -75.9% | 73.3% |
| Avg | -80.4% | -83.1% | 66.7% |
| Low | -81.6% | -89.6% | 61.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.